Stock TXTM PROTEXT MOBILITY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News ProText Mobility, Inc.

Equities

TXTM

US74371E2046

Market Closed - OTC Markets
Other stock markets
 03:59:54 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.0023 USD +27.78% Intraday chart for ProText Mobility, Inc. +27.78% +35.29%
2022 Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update CI
2021 ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PROTEXT MOBILITY, INC. (TXTM) ADDRESSES ALLEGED PROMOTIONAL ACTIVITY AND OTC MARKETS CE DESIGNATION
AQ
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE
EQ
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE
AQ
Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update
CI
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PROVIDE SHAREHOLDERS UPDATE AND NEAR TERM ROAD MAP
AQ
ProText Mobility : Quarterly Report - Protext Q3 2021 - Amended
PU
ProText Mobility : Quarterly Report
PU
ProText Mobility : Notification of Late Filing
PU
PROTEXT MOBILITY ANNOUCNES SIGNING OF LETTER OF INTENT TO ACQUIRE PREMIER VODKA BRAND
AQ
ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility
CI
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)
NE
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Signs Letter of Intent with USA-based Protext Pharma (TXTM) for Commercialization of Next Generation Live Cannabis and Hemp Extraction Technology
NE
ProText Mobility, Inc. cancelled the acquisition of 60% in Growprocess, Inc.
CI
Protext Pharma to Acquire Cannabis Blockchain Company Growprocess, Inc.
GL
ProText Mobility, Inc. signed a letter of intent to acquire 60% in Growprocess, Inc.
CI
Protext Pharma : Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance
MW
Protext Pharma : to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes
MW
Protext Mobility : Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License
MW
ProText Mobility, Inc. has Changed its Name to Protext Pharma, Inc
CI
Protext Mobility : Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial
MW
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TXTM Stock
  4. News ProText Mobility, Inc.